The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of KN046 in patients with thymic carcinoma who failed immune checkpoint inhibitors.
 
Barbara Ting-wen Ma
Consulting or Advisory Role - MJH Life Sciences
 
Victoria Dai
Stock and Other Ownership Interests - Amgen; AstraZeneca/MedImmune; Catalent; HCA Healthcare; Illumina; Lexicon; NextCure; Personalis; Surgery Partners
Research Funding - Alphamab (Inst); AstraZeneca/MedImmune (Inst)
 
June Greenberg
No Relationships to Disclose
 
Karla V. Ballman
Consulting or Advisory Role - Agenus; Medtronic; Takeda
Patents, Royalties, Other Intellectual Property - Prostate cancer signature patent (Inst)
Expert Testimony - Janssen Oncology; Janssen Oncology; Lilly; Sanofi
 
Li Li
Employment - Jiangsu Alphamab Biopharmaceuticals
 
Christine Ann Garcia
No Relationships to Disclose
 
Ronald J. Scheff
No Relationships to Disclose
 
Ashish Saxena
Honoraria - Association of Physician Assistants in Oncology; Genentech/Roche; Medscape; MJH Life Sciences; MJH Life Sciences; MJH Life Sciences; MJH Life Sciences; MJH Life Sciences; PER; PER
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca/MedImmune; AstraZeneca/MedImmune; Blueprint Medicines; Jazz Pharmaceuticals
Research Funding - Alphamab (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Bayer (Inst); Blueprint Medicines (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences; Celgene (Inst); Daiichi Sankyo (Inst); Endocyte (Inst); Genentech (Inst); Guardant Health (Inst); Immunomedics (Inst); Jounce Therapeutics (Inst); Merck (Inst); Novocure (Inst); Seagen (Inst); Spectrum Pharmaceuticals (Inst); Top Alliance BioScience (Inst); VM Pharma (Inst)
 
Giuseppe Giaccone
Consulting or Advisory Role - Daiichi; Eisai; Janssen Oncology; Novartis; Radiomics; Sanofi; Sanofi/Regeneron; Spectrum Pharmaceuticals
Research Funding - Cantargia AB (Inst); Karyopharm Therapeutics (Inst); MedImmune (Inst)